Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acelyrin, Inc. (SLRN) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acelyrin, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1962918.
Total stock buying since 2023: $47,651,976.
Total stock sales since 2023: $333,521.
Total stock option exercises since 2023: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 25,110 | $68,900 | 0 | $0 |
| 2024 | 0 | $0 | 36,354 | $264,621 | 0 | $0 |
| 2023 | 2,647,332 | $47,651,976 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 0 | $0 | 25,110 | $68,900 | 0 | $0 |
| 2024-07 | 0 | $0 | 1 | $6 | 0 | $0 |
| 2024-04 | 0 | $0 | 9,961 | $66,021 | 0 | $0 |
| 2024-02 | 0 | $0 | 15,701 | $119,406 | 0 | $0 |
| 2024-01 | 0 | $0 | 10,691 | $79,188 | 0 | $0 |
| 2023-05 | 2,647,332 | $47,651,976 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-17 | Mpofu Shephard (Chief Medical Officer) | Sale | 3,211 | 2.74 | 8,810 |
| 2025-03-17 | Murugan Amar (Chief Legal Officer) | Sale | 3,913 | 2.74 | 10,737 |
| 2025-03-17 | Kim Mina (Chief Executive Officer) | Sale | 17,986 | 2.74 | 49,353 |
| 2024-07-17 | Becker Daniel J. (Director) | Sale | 1 | 6.86 | 6 |
| 2024-04-01 | Lin Shao-lee (Chief Executive Officer) | Sale | 9,961 | 6.63 | 66,021 |
| 2024-02-20 | Lin Shao-lee (Chief Executive Officer) | Sale | 15,701 | 7.61 | 119,406 |
| 2024-01-02 | Lin Shao-lee (Chief Executive Officer) | Sale | 10,691 | 7.41 | 79,188 |
| 2023-05-09 | Oyston Ronald (Chief People Officer) | Buy | 1,026 | 18.00 | 18,468 |
| 2023-05-09 | Peloso Paul (Chief Medical Officer) | Buy | 6,000 | 18.00 | 108,000 |
| 2023-05-09 | Becker Daniel J. (Director) | Buy | 3,000 | 18.00 | 54,000 |
| 2023-05-09 | Kim Mina (Chief Legal & Admin. Officer) | Buy | 5,000 | 18.00 | 90,000 |
| 2023-05-09 | Gosebruch Henry O (Director) | Buy | 50,000 | 18.00 | 900,000 |
| 2023-05-09 | Dier Mardi (CFO and CBO) | Buy | 7,306 | 18.00 | 131,508 |
| 2023-05-09 | Svoronos Dawn (Director) | Buy | 15,000 | 18.00 | 270,000 |
| 2023-05-09 | Harper Sean E (10% Owner) | Buy | 1,250,000 | 18.00 | 22,500,000 |
| 2023-05-09 | Seidenberg Beth C (Director) | Buy | 1,310,000 | 18.00 | 23,580,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SLRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acelyrin, Inc. (symbol SLRN, CIK number 1962918) see the Securities and Exchange Commission (SEC) website.